文章摘要
药品技术转让申报资料的存在问题分析
Analyzed for Existing Problems in the Application Materials of Drug Technology Transfer
投稿时间:2020-01-20  修订日期:2020-07-13
DOI:
中文关键词: 药品  技术转让  申报资料  补正资料意见
英文关键词: drug  technology transfer  application materials  requirements of supplementary information
基金项目:广东省食品药品监督管理局科技创新项目(No.GDFDA KJ01-2018)
作者单位邮编
李璇 广东省药品监督管理局审评认证中心 510080
陈佩毅 Center For Certification And Evaluation,Guangdong Drug Administration 
王爽 广东省药品监督管理局审评认证中心 
王晓英 广东省药品监督管理局审评认证中心 
黎依娴 广东省药品监督管理局审评认证中心 
张一凡 广东省药品监督管理局审评认证中心 
毕军 广东省药品监督管理局审评认证中心 
江映珠* 广东省药品监督管理局审评认证中心 510080
摘要点击次数: 324
全文下载次数: 0
中文摘要:
      目的:为拟开展技术转让同类变更研究的申请人提供参考和建议。方法:收集广东省药品审评认证中心对药品技术转让申请发出的补充资料通知,结合资料分类和品种类别对补正资料意见进行统计分析。 结果:对59份补充资料通知中的257条补正资料意见进行归纳分析,其中条数占比最高的前5项为质量标准及分析方法验证(23.7%)、质量对比分析(19.5%)、生产工艺和过程控制(12.8%)、物料控制(10.5%)、设备及验证(8.9%);对补正资料意见具体内容进行分析,中药品种存在问题主要集中在生产过程控制、中间体的质量对比研究和稳定性研究部分;化学原料药的起始物料和关键物料的质量标准、过程控制参数部分的补充资料要求较多;化学药品在立题合理性、质量研究部分存在较多补充资料要求。结论:对技术转让申报资料中存在准备不足、研究不充分的问题进行了分析,按申报品种的不同类别提出了研究建议。拟开展同类变更研究的申请人可以此为参考,在研究立项之时就应制定全面、规范的研究方案,提升变更研究的质量和效率。
英文摘要:
      Objective:To provide references and suggestions for applicants of the change research of drug technology transfer. Methods:This study collected the requirements, which were made by the Center For Certification And Evaluation, Guangdong Drug Administration, of supplementary information for application materials of drug technology transfer. Items were classified in sorts, and analyzed for existing problems. Results: Analyzed 257 supplementary informations of 59 requirements, most requirements of supplementary information appeared in 5 aspects, namely the quality standards and analytic method validation(23.7%) , quality contrast research (19.5%), production technology and process control (12.8%) ,control of materials(10.5%),equipment and the validation (8.9%).According to the different classifications of the application varieties, the problems of traditional Chinese medicine(TCM) are mainly due to process control, quality contrast research and stability study of intermediate. Most requirements to Active Pharmaceutical Ingredient (API) are extend to the quality standards of starting material, and control parameters of the process. The reasonableness and quality research of chemicals received more supplementary informations. Conclusion: Aiming at the applicants’ lack of information and research, this paper gave rational recommendations according to the different classifications of the application varieties. Researchers and applicants that plan to carry out change research of drug technology transfer can take this as reference, and should make comprehensive and regulated research programs at the establishment of the change research, so as to improve the quality and efficiency of the change research.
View Fulltext   查看/发表评论  下载PDF阅读器
关闭